dapagliflozin,empagliflozin
astrazeneca,Boehringer Ingelheim,eli lilly
['dapagliflozin']
another year, another sglt2 inhibitor trial at #esccongress. this time, it's dapagliflozin showing hfpef benefit. how do deliver &amp; emperor-preserved compare? check out the graphic below and our article on deliver results for more insight: #esc22 
Asst managing editor w/ @practicalcardio, @endocrinenetwrk & @rheumatologynet. formerly @njdotcom, @starnewsgroup & @poconorecord. opinions are my own. #Ramily